Q & A
Ask a question
There are no questions yet
🇬🇧 Michael (UK) — ordered Erlocip 150mg Tablet · 14 min ago
🇨🇦 Priya (Canada) — bulk enquiry · 38 min ago
🇦🇺 Order shipped to Melbourne — DHL Express tracked
🇫🇷 Laurent (France) — 4th repeat order confirmed ✓
🇸🇬 Bulk supply to Singapore clinic — 40 units confirmed
🇩🇪 Klaus (Germany) — enquiry for Erlocip 150mg Tablet
🇺🇸 Dr. Chen (USA) — hospital order confirmed
🇦🇪 Ahmad (UAE) — 5★ verified buyer
🇳🇱 Order to Netherlands · discreet pack
🇯🇵 Kenji (Japan) — export docs requested
🇬🇧 Michael (UK) — ordered Erlocip 150mg Tablet · 14 min ago
🇨🇦 Priya (Canada) — bulk enquiry · 38 min ago
🇦🇺 Order shipped to Melbourne — DHL Express tracked
🇫🇷 Laurent (France) — 4th repeat order confirmed ✓
🇸🇬 Bulk supply to Singapore clinic — 40 units confirmed
🇩🇪 Klaus (Germany) — enquiry for Erlocip 150mg Tablet
🇺🇸 Dr. Chen (USA) — hospital order confirmed
🇦🇪 Ahmad (UAE) — 5★ verified buyer
🇳🇱 Order to Netherlands · discreet pack
🇯🇵 Kenji (Japan) — export docs requested
🩺 Anti Cancer
Sale!
Erlocip 150mg Tablet
Manufactured by / Trademark: Cipla
40 viewing now
19 enquiries / 48 hrs
9 shipped / week
Our Price
$6,176
Global Retail
$9,502
Save $3,326 (35% off)
In Stock — Ships within 48 hrs
📦 Bulk discounts available — enquire for volume pricing
🔥 3 people ordered in the last 24 hours · Only 8 units remaining
Genuine Stock
Export Docs
Discreet Pack
Cold-Chain
🚚 Estimated Delivery to Your Country
🇬🇧🇩🇪🇫🇷
Europe
7–10 days
Express courier
🇺🇸🇨🇦🇦🇺
US / CA / AU
10–14 days
EMS / courier
🇦🇪🇸🇦🇯🇵
Middle East / Asia
5–8 days
Express courier
Trustpilot
★★★★★
Excellent
4.6 / 5
21 verified reviews
🔒 Secure Payment Options
SSL encrypted · All transactions are private & secure
Erlocip 150mg Tablet (Erlotinib) is an oral targeted therapy used in the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the action of the epidermal growth factor receptor (EGFR), effectively slowing cancer cell growth and proliferation.
Erlocip 150mg Tablet contains Erlotinib, a potent oral tyrosine kinase inhibitor that targets the epidermal growth factor receptor (EGFR). This medication is primarily indicated for the treatment of advanced non-small cell lung cancer (NSCLC) and pancreatic cancer. By blocking EGFR signaling, Erlotinib helps to impede tumor growth and spread, making it a crucial component of targeted cancer therapy.
Key Features:
- Contains Erlotinib, a leading oral targeted therapy
- Used for treating non-small cell lung cancer (NSCLC) and pancreatic cancer
- Inhibits the action of EGFR to slow down cancer cell growth
- Convenient oral administration for easy patient compliance
- Often used as part of a comprehensive cancer treatment regimen
Frequently Ordered Together
View all →
Reviews
There are no reviews yet